Naldebain for Pain Management of Laparoscopic Cholecystectomy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

January 21, 2022

Study Completion Date

April 18, 2022

Conditions
Pain, PostoperativePain, ChronicCholecystitisQuality of Life
Interventions
DRUG

Dinalbuphine sebacate

Naldebain dissolved in benzyl benzoate and sesame oil (a total volume of 2ml) will be prepared in a 5-ml syringe 30 min before administration. Intramuscular injection into the gluteal muscles will be performed by an anesthesiologist under sonography-guidance.

DRUG

Placebo solution

Benzyl benzoate and sesame oil served as placebo solution (a total volume of 2ml) will be prepared in a 5-ml syringe 30 min before administration. Intramuscular injection into the gluteal muscles will be performed by an anesthesiologist under sonography-guidance.

Trial Locations (1)

824

E-Da Hospital, Yanchao

All Listed Sponsors
lead

E-DA Hospital

OTHER

NCT04808544 - Naldebain for Pain Management of Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter